Beneficial effects of ivabradine in patients with heart failure, low ejection fraction, and heart rate above 77 b.p.m.

AIMS: Ivabradine has been approved in heart failure with reduced ejection fraction (HFrEF) and elevated heart rate despite guideline‐directed medical therapy (GDMT) to reduce cardiovascular (CV) death and hospitalization for worsening HF. The median value of 77 b.p.m. is the lower bound selected for...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:ESC Heart Fail
Hoofdauteurs: Bouabdallaoui, Nadia, O'Meara, Eileen, Bernier, Virginie, Komajda, Michel, Swedberg, Karl, Tavazzi, Luigi, Borer, Jeffrey S., Bohm, Michael, Ford, Ian, Tardif, Jean‐Claude
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Original Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6989297/
https://ncbi.nlm.nih.gov/pubmed/31591826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12513
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items